News
PLRZ
10.36
-3.85%
-0.42
Polyrizon Files First-Half 2026 Results Showing Higher Assets and Wider Loss
TipRanks · 4h ago
Polyrizon Ltd. GAAP EPS of -$0.79
Seeking Alpha · 5h ago
Weekly Report: what happened at PLRZ last week (0921-0925)?
Weekly Report · 15h ago
Polyrizon enrolls first patient in U.S. study of NASARIX
TipRanks · 6d ago
Polyrizon Enrolls First Patient In U.S. NASARIX Allergy Blocker Trial, Entering Clinical Stage
Benzinga · 6d ago
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Barchart · 6d ago
Weekly Report: what happened at PLRZ last week (0914-0918)?
Weekly Report · 09/21 09:52
Polyrizon files to sell 404,166 ordinary shares for holders
TipRanks · 09/18 20:35
Weekly Report: what happened at PLRZ last week (0907-0911)?
Weekly Report · 09/14 09:55
Weekly Report: what happened at PLRZ last week (0831-0904)?
Weekly Report · 09/07 09:51
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement
TipRanks · 09/04 14:57
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Barchart · 09/04 10:58
Polyrizon Announces $4 Mln Registered Direct Offering And Private Placement
NASDAQ · 09/03 16:20
Polyrizon prices $4M registered direct offering
Seeking Alpha · 09/03 13:13
Polyrizon announces $4.0M registered direct offering
TipRanks · 09/03 12:55
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Barchart · 09/03 07:50
Polyrizon Completes Clinical Site Contracting For NASARIX Trial; Advances Into FIH Study Execution
NASDAQ · 09/02 14:35
Polyrizon completes all five U.S. site contracts for Nasarix allergy study
TipRanks · 09/02 13:16
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
Barchart · 09/02 06:32
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/31 17:06
More
Webull provides a variety of real-time PLRZ stock news. You can receive the latest news about Polyrizon Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PLRZ
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..